Supply reliability has been a frequent pain point in the GLP-1 space over the past three or four years, with unprecedented demand exceeding manufacturing capacity and resulting in years-long drug shortages across US and Europe
is supported by NIH research grants R01MD014712, U2CDK114886, UL1TR002319, U54DK083912, U01DK100846, OT2HL161847, UM1AI109568, OT2OD032581 and CDC project numbers 75D301-21-P-12254 and 75D301-23-C-18264
By supporting meaningful weight loss and glucose control, both medications may help improve overall health outcomes
de Almeida AJPO, de Oliveira JCPL, da Silva Pontes LV, de Souza Jnior JF, Gonalves TAF, Dantas SH, et al